Theranica
Theranica Bio-Electronics develops prescription digital therapeutics and wearable devices for the management of neurological pain diseases. Its primary product, Nerivio, is a remote electrical neuromodulation (REN) wearable that stimulates peripheral nerves in the upper arm to trigger a natural pain inhibition mechanism. The technology is specifically designed to treat patients suffering from migraine by inducing conditioned pain modulation to shut down pain signals.
Visit websiteNetanya, Israel
Digital Therapeutics
Medical Devices
Neurology
Healthtech
Funding summary
- Total raised
- €35.6M
- Funding rounds
- 2
Investors in Theranica
Investors on record for Theranica. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Theranica?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors